ResMed Inc. RMD
Analyst Ratings
- Consensus
- Hold — 4 Buy · 8 Hold · 0 Sell (12 analysts)
- Avg. Price Target
- $240.82 (+5.4% upside)
Key Stats
- Today's Range
- $225.08 – $229.57
- 50-Day Range
- $190.21 – $242.40
- 52-Week Range
- $180.26 – $293.81
- Volume
- 1.03 million shs
- Average Volume
- 1.42 million shs
- Market Cap
- $32.93 billion
- P/E Ratio
- 21.90
- Dividend Yield
- 1.16%
Valuation
- P/E Ratio
- 21.90
- Price / Book
- 5.00
- Price / Sales
- 5.82
Dividend
- Dividend Yield
- 1.16%
- Annual Dividend
- $2.64
- Payout Ratio
- 25.31%
- Ex-Dividend Date
- 2026-08-20
Short Interest
- Short Interest
- 4.04%
- Days to Cover
- 15.61
Financials (TTM)
- Revenue
- $5.65 billion
- Net Income
- $1.52 billion
- Net Margin
- 26.94%
- Return on Equity
- 23.13%
- Debt-to-Equity
- 0.06
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Related Stocks
Compare head-to-head: RMD vs SYK·RMD vs BSX·RMD vs BAX·RMD vs GMED
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.